Clinical Trial Update: A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD [Phase 3]

View source ↗

Summary

Phase 3 open-label extension study of MDMA-assisted psychotherapy for post-traumatic stress disorder has completed, with results posted in November 2024. The sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: PTSD | Phase 3 | Status: COMPLETED | Results posted: 2024-11-29